BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26637184)

  • 21. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.
    van Horssen J; Schreibelt G; Drexhage J; Hazes T; Dijkstra CD; van der Valk P; de Vries HE
    Free Radic Biol Med; 2008 Dec; 45(12):1729-37. PubMed ID: 18930811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
    Bouafia A; Golmard JL; Thuries V; Sazdovitch V; Hauw JJ; Fontaine B; Seilhean D
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):579-90. PubMed ID: 23659577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
    van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
    Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymes involved in l-lactate metabolism in humans.
    Adeva M; González-Lucán M; Seco M; Donapetry C
    Mitochondrion; 2013 Nov; 13(6):615-29. PubMed ID: 24029012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.
    Zeis T; Allaman I; Gentner M; Schroder K; Tschopp J; Magistretti PJ; Schaeren-Wiemers N
    Brain Behav Immun; 2015 Aug; 48():313-25. PubMed ID: 25937052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1).
    Moreels M; Vandenabeele F; Dumont D; Robben J; Lambrichts I
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):532-46. PubMed ID: 18005096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M; Liu R; Guo L; Li C; Tan G
    APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
    Witte ME; Nijland PG; Drexhage JA; Gerritsen W; Geerts D; van Het Hof B; Reijerkerk A; de Vries HE; van der Valk P; van Horssen J
    Acta Neuropathol; 2013 Feb; 125(2):231-43. PubMed ID: 23073717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE; Nichols PP; Bates D; Turnbull DM
    Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions.
    Tai YH; Engels D; Locatelli G; Emmanouilidis I; Fecher C; Theodorou D; Müller SA; Licht-Mayer S; Kreutzfeldt M; Wagner I; de Mello NP; Gkotzamani SN; Trovò L; Kendirli A; Aljović A; Breckwoldt MO; Naumann R; Bareyre FM; Perocchi F; Mahad D; Merkler D; Lichtenthaler SF; Kerschensteiner M; Misgeld T
    Nat Metab; 2023 Aug; 5(8):1364-1381. PubMed ID: 37430025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysfunctional TCA-Cycle Metabolism in Glutamate Dehydrogenase Deficient Astrocytes.
    Nissen JD; Pajęcka K; Stridh MH; Skytt DM; Waagepetersen HS
    Glia; 2015 Dec; 63(12):2313-26. PubMed ID: 26221781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model.
    Naseri NN; Xu H; Bonica J; Vonsattel JP; Cortes EP; Park LC; Arjomand J; Gibson GE
    J Neuropathol Exp Neurol; 2015 Jun; 74(6):527-37. PubMed ID: 25978848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
    Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
    Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.
    Hendrickx DA; Koning N; Schuurman KG; van Strien ME; van Eden CG; Hamann J; Huitinga I
    J Neuropathol Exp Neurol; 2013 Feb; 72(2):106-18. PubMed ID: 23334594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C; Kidd G; Mörk S; Rudick R; Trapp BD
    Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis.
    Kaushik DK; Bhattacharya A; Mirzaei R; Rawji KS; Ahn Y; Rho JM; Yong VW
    J Clin Invest; 2019 May; 129(8):3277-3292. PubMed ID: 31112527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.